RxDoctor Payments Data

Gulshan Parasher, MD

Internal Medicine · Albuquerque, NMNPI 1598786733

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (58.6%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 24 manufacturers reported payments, led by AbbVie at 53.0% of the total. Reporting peaked in 2019 at $34,334 and has fallen 96.2% since, to $1,319 in 2025. Among internal medicine clinicians in NM with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$65,810in general payments, 2019–2025

Across 211 payments — averaging $311.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$35K
  • Boston Scientific$13K
  • Wilson Cook Medical Incorporated$12K
  • Cook Medical LLC$2K
  • Medtronic$924
  • Ovesco Endoscopy USA, Inc.$472
  • plus $2K from 18 others
$79,627in research payments, 2019–2025

Across 11 payments — averaging $7238.86 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • AbbVie$80K

What the payments were for

  • Consulting fees$13,90021%
  • Speaking & faculty fees$38,55059%
  • Travel & lodging$5,5788%
  • Food & beverage$6,58210%
  • Education$1,2002%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$65,810 in reported general payments places this provider in the 95th percentile of 578 internal medicine providers in New Mexico.

See all internal medicine providers in New Mexico

Medicare billing

Part B allowed, 2024
$67,572
Medicare patients
201
Services billed
403

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl13$314

Paid to pharmacies, not to this prescriber.

Other internal medicine in Albuquerque

See the full list for New Mexico

Where these figures come from

Is this you, or does something look wrong? →